The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study
- PMID: 10379748
- DOI: 10.1097/00005392-199907000-00023
The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study
Abstract
Purpose: We evaluated the effects of transurethral needle ablation and prostate resection on pressure flow urodynamic parameters in men with benign prostatic hyperplasia (BPH), compared symptomatic and objective parameters of efficacy 6 months after initial treatment, and determined whether urodynamic assessment may predict symptomatic improvement.
Materials and methods: We enrolled 121 patients with clinical BPH, American Urological Association symptom index of 13 or greater and maximum urinary flow of 12 ml. per second or less in a randomized study comparing transurethral needle ablation to prostate resection at 7 institutions in the United States. Patients underwent baseline and followup assessments at 6 months, including pressure flow studies.
Results: Patients who underwent each procedure had statistically and clinically significant improvement in symptom index, BPH impact index and quality of life score. After needle ablation and prostate resection maximum flow improved from 8.8 to 13.5 (p<0.0001) and 8.8 to 20.8 ml. per second (p<0.0001), detrusor pressure at maximum flow decreased from 78.7 to 64.5 (p = 0.036) and 75.8 to 54.9 cm. water (p<0.001), and the Abrams-Griffiths number decreased from 61.2 to 37.2 (p<0.001) and 58.3 to 10.9 (p<0.001), respectively. At 6 months the differences in transurethral needle ablation and prostate resection were significant in terms of maximum flow (p<0.001) and the Abrams-Griffiths number (p<0.001) but not detrusor pressure at maximum flow or symptom assessment tools. The presence or absence of urinary obstruction at baseline did not predict the degree of symptomatic improvement in either treatment group.
Conclusions: Transurethral needle ablation and prostate resection induce statistically and clinically significant improvement in various quantitative symptom assessment questionnaires at 6 months. The parameters of free flow rates and invasive pressure flow studies also significantly improve after each treatment. However, transurethral prostate resection induces a significantly greater decrease in the parameters of obstruction. Baseline urodynamic parameters do not predict the degree of symptomatic improvement and they may not be helpful in patient selection for transurethral needle ablation.
Similar articles
-
A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.J Urol. 1998 May;159(5):1588-93; discussion 1593-4. doi: 10.1097/00005392-199805000-00048. J Urol. 1998. PMID: 9554360 Clinical Trial.
-
Transurethral needle ablation of the prostate: report of initial United States clinical trial.J Urol. 1996 Aug;156(2 Pt 1):413-9. J Urol. 1996. PMID: 8683692 Clinical Trial.
-
The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.J Urol. 1997 Jul;158(1):105-10; discussion 110-1. doi: 10.1097/00005392-199707000-00029. J Urol. 1997. PMID: 9186334 Clinical Trial.
-
Transurethral needle ablation of the prostate.Curr Opin Urol. 2007 Jan;17(1):7-11. doi: 10.1097/MOU.0b013e328011ab98. Curr Opin Urol. 2007. PMID: 17143104 Review.
-
Urodynamic implications of benign prostatic hyperplasia.Urologe A. 1990 Jan;29(1):1-4. Urologe A. 1990. PMID: 1690484 Review.
Cited by
-
Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia.BMC Urol. 2006 Jun 21;6:14. doi: 10.1186/1471-2490-6-14. BMC Urol. 2006. PMID: 16790044 Free PMC article.
-
How do transurethral needle ablation of the prostate and transurethral microwave thermotherapy compare with transurethral prostatectomy?Curr Urol Rep. 2003 Aug;4(4):297-306. doi: 10.1007/s11934-003-0088-x. Curr Urol Rep. 2003. PMID: 12882722 Review. No abstract available.
-
Long-term results of surgical techniques and procedures in men with benign prostatic hyperplasia.Curr Urol Rep. 2011 Aug;12(4):265-73. doi: 10.1007/s11934-011-0193-1. Curr Urol Rep. 2011. PMID: 21484456 Review.
-
Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.Clinicoecon Outcomes Res. 2017 Dec 29;10:29-43. doi: 10.2147/CEOR.S148195. eCollection 2018. Clinicoecon Outcomes Res. 2017. PMID: 29343977 Free PMC article.
-
[S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].Urologe A. 2016 Feb;55(2):195-207. doi: 10.1007/s00120-015-3983-0. Urologe A. 2016. PMID: 26518304 German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical